Express Pharma

India and UK to conduct clinical trials of Ashwagandha for promoting COVID-19 recovery

MoU signed between All India Institute of Ayurveda (under the Ministry of Ayush) and the UK’s London School of Hygiene and Tropical Medicine

0 211

The Ministry of Ayush has collaborated with the UK’s London School of Hygiene and Tropical Medicine (LSHTM) to conduct a study on Ashwagandha for promoting recovery from COVID-19, a statement has said.

It also said that the All India Institute of Ayurveda (AIIA), an autonomous body under the Ministry of Ayush and LSHTM recently signed a Memorandum of Understanding (MoU) to conduct clinical trials of Ashwagandha on 2,000 people in three UK cities – Leicester, Birmingham and London (Southall and Wembley).

Ashwagandha (Withania somnifera), commonly known as ‘Indian winter cherry,’ is a traditional Indian herb that boosts energy, reduces stress and makes the immune system stronger. It is an easily accessible, over-the-counter nutritional supplement in the UK and has a proven safety profile. The positive effects of Ashwagandha have been observed in long COVID, which is a multi-system disease with no evidence of its effective treatment or management, according to the statement.

It also mentioned that the successful completion of the trial can be a major breakthrough and give scientif